Stay updated with breaking news from Stuarta Arbuckle. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com upgraded shares of Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) from a buy rating to a strong-buy rating in a report issued on Friday morning. A number of other equities research analysts also recently issued reports on VRTX. Robert W. Baird downgraded shares of Vertex Pharmaceuticals from a neutral rating to an underperform rating and […]
Benjamin F. Edwards & Company Inc. increased its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 30.5% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,672 shares of the pharmaceutical company’s stock after purchasing an additional 859 […]
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) released its quarterly earnings results on Monday. The pharmaceutical company reported $4.76 earnings per share for the quarter, topping analysts’ consensus estimates of $3.61 by $1.15, Briefing.com reports. The firm had revenue of $2.69 billion during the quarter, compared to the consensus estimate of $2.58 billion. Vertex Pharmaceuticals […]
Ifrah Financial Services Inc. cut its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 3.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,557 shares of the pharmaceutical company’s stock after selling 179 shares during the quarter. Ifrah Financial […]
Sapient Capital LLC purchased a new position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 34,486 shares of the pharmaceutical company’s stock, valued at approximately $14,032,000. Several other […]